Compare Medtronic PLC (MDT) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Open Text Corporation — how do they compare? Medtronic PLC trades at $82.83 (market cap $106.61B), while Open Text Corporation trades at $23.13 (market cap $5.61B). The key difference: Medtronic PLC is far larger — about 19× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.72%). Which is the better fit depends on your goals.
| MDT | OTEX | |
|---|---|---|
Market Cap | $106.61B | $5.61B |
Sector | Health | Technology |
52-Week High | $105.35 | $39.69 |
52-Week Low | $73.75 | $20.01 |
Enterprise Value | $125.36B | $10.77B |
Dividend Yield | 3.46% | 4.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
OpenText (OTEX) trades at $23.33, up 0.26% with a bullish technical signal from moving averages. The company shows solid fundamentals with a P/E of 11.3, EV/EBITDA of 6.71, and consistent earnings beats in recent quarters. Recent developments include a $105 million European AI investment and board appointments, while maintaining a 4.7% dividend yield.
OTEX presents value opportunity with attractive valuation multiples and strong cash flow generation. Key risks include execution challenges in AI strategy and competitive software market pressures. Analyst consensus targets $29.75 (27.5% upside) with 42% buy ratings, though majority maintain hold stance awaiting clearer growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
